Agilent Technologies Dirección

Dirección controles de criterios 4/4

El CEO de Agilent Technologies' es Mike McMullen , nombrado en Sep 2014, tiene una permanencia de 9.58 años. compensación anual total es $16.02M, compuesta por 8.2% salario y 91.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.068% de las acciones de la empresa, por valor de €26.04M. La antigüedad media del equipo directivo y de la junta directiva es de 6.9 años y 8.6 años, respectivamente.

Información clave

Padraig McDonnell

Chief Executive Officer (CEO)

US$3.3m

Compensación total

Porcentaje del salario del CEO	18.5%
Permanencia del CEO	less than a year
Participación del CEO	0.009%
Permanencia media de la dirección	4.5yrs
Promedio de permanencia en la Junta Directiva	6.8yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Padraig McDonnell en comparación con los beneficios de Agilent Technologies?
Fecha	Compensación total	Salario	Ingresos de la empresa
Jan 31 2024	n/a	n/a	US$1b
Oct 31 2023	US$3m	US$606k	US$1b
Jul 31 2023	n/a	n/a	US$1b
Apr 30 2023	n/a	n/a	US$1b
Jan 31 2023	n/a	n/a	US$1b
Oct 31 2022	n/a	n/a	US$1b
Jul 31 2022	n/a	n/a	US$1b
Apr 30 2022	n/a	n/a	US$1b
Jan 31 2022	n/a	n/a	US$1b
Oct 31 2021	US$3m	US$495k	US$1b

Compensación vs. Mercado: La compensación total de Padraig($USD3.27M) está por debajo de la media de empresas de tamaño similar en el mercado German ($USD5.55M).

Compensación vs. Ingresos: La compensación de Mike ha sido consistente con los resultados de la empresa en el último año.

CEO

Padraig McDonnell

less than a year

Permanencia

US$3,272,898

Compensación

Mr. Padraig McDonnell serves as Chief Operating Officer at Agilent Technologies, Inc. from February 2024 and serves as its CEO, President & Director since May 01, 2024. He served as Senior Vice President a...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Padraig McDonnell	CEO, COO	less than a year	US$3.27m	0.0093% $ 3.6m
Robert McMahon	Senior VP	5.7yrs	US$4.81m	0.032% $ 12.2m
Henrik Ancher-Jensen	Senior VP and President of Order Fulfillment & Supply Chain	10.7yrs	US$3.33m	0.0032% $ 1.2m
Rodney Gonsalves	Principal Accounting Officer	9yrs	sin datos	0.0073% $ 2.8m
John Kohl	Senior Vice President & Chief Information Officer	8.3yrs	sin datos	sin datos
P. Chiu	VP, Interim General Counsel & Secretary	less than a year	sin datos	sin datos
Dominique Grau	Senior Vice President of Human Resources & Global Communications	9.8yrs	US$2.21m	0.031% $ 12.1m
Allison Ballmer	Senior Vice President of Strategy & Corporate Development	3.3yrs	sin datos	sin datos
Yvonne Mackie	MD of UK & Ireland Operations and VP of Human Resources - Europe	19.3yrs	sin datos	sin datos
Jenipher Dalton	Senior VP	3.4yrs	sin datos	sin datos
Philip Binns	Senior VP of Agilent and President of Life Sciences & Applied Markets Group	less than a year	sin datos	0.0014% $ 558.7k
Jonah Kirkwood	Senior Vice President	less than a year	sin datos	sin datos

4.5yrs

Permanencia media

57.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de AG8 se considera experimentado (4.5 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Padraig McDonnell	CEO, COO	no data	US$3.27m	0.0093% $ 3.6m
Heidi Fields	Independent Director	24.3yrs	US$331.85k	0% $ 0
Otis Brawley	Independent Director	2.5yrs	US$331.85k	0% $ 0
George Scangos	Independent Director	13.3yrs	US$351.85k	0.0061% $ 2.4m
Dow Wilson	Independent Director	6.2yrs	US$356.85k	0% $ 0
Boon Hwee Koh	Independent Non-Executive Chairman	21yrs	US$486.85k	0.021% $ 7.9m
Daniel Podolsky	Independent Director	8.8yrs	US$341.85k	0% $ 0
Mala Anand	Independent Director	5.2yrs	US$331.85k	0.0043% $ 1.7m
Mikael Dolsten	Independent Director	2.7yrs	US$341.85k	0.0019% $ 751.4k
Hans Edgar Bishop	Independent Director	6.8yrs	US$331.85k	0% $ 0
Susan Rataj	Independent Director	8.7yrs	US$341.85k	0.0091% $ 3.5m

6.8yrs

Permanencia media

65.5yo

Promedio de edad

Junta con experiencia: La junta directiva de AG8 se considera experimentada (8.6 años de antigüedad promedio).

Agilent Technologies Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

Agilent Technologies, Inc. Announces CEO Changes, effective May 1, 2024

Agilent Technologies, Inc., Annual General Meeting, Mar 14, 2024

Insider recently sold €1.9m worth of stock

Agilent Technologies, Inc. Announces Resignation of Sam Raha as Senior Vice President of the Company and President of the Diagnostics and Genomics Group

Agilent Technologies, Inc. Announces Management Changes

Recent updates

Agilent Technologies, Inc. to Report Q2, 2024 Results on May 29, 2024

Agilent Announces the NovoCyte Opteon, A Cutting-Edge Spectral Flow Cytometry Solution

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

Agilent Technologies, Inc. At AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics

Agilent Technologies Inc. Launches New Advanced Dilution System to Increase Lab Efficiency

First quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Agilent Technologies, Inc. Announces CEO Changes, effective May 1, 2024

Agilent Technologies, Inc. to Report Q1, 2024 Results on Feb 27, 2024

Agilent Technologies, Inc. Announces New Proteoanalyzer System

Agilent Technologies, Inc., Annual General Meeting, Mar 14, 2024

Agilent Makes Strategic Updates to Organizational Structure

Insider recently sold €1.9m worth of stock

Agilent Technologies Inc. Announces the Addition of Water Immersion and New Confocal Spinning Disk Technology to the Biotek Cytation C10 Confocal Imaging Reader

Full year 2023 earnings released: EPS: US$4.22 (vs US$4.19 in FY 2022)

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Fiscal Year 2024

Agilent Technologies Inc. Increases Quarterly Cash Dividend, Payable on January 24, 2024

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Now 20% undervalued after recent price drop

Agilent Technologies, Inc. Announces Resignation of Sam Raha as Senior Vice President of the Company and President of the Diagnostics and Genomics Group

Agilent Technologies, Inc. to Report Q4, 2023 Results on Nov 20, 2023

Now 22% undervalued after recent price drop

Agilent Technologies, Inc. Announces Quarter Dividend, Payable on October 25, 2023

Exact Sciences Corporation (NasdaqCM:EXAS) agreed to acquire Resolution Bioscience, Inc. from Agilent Technologies, Inc. (NYSE:A).

Now 20% undervalued

Agilent Technologies, Inc. Announces Management Changes

Agilent Technologies, Inc. Appoints Philip Binns as President of Life Sciences and Applied Markets Group

New minor risk - Earnings quality

Agilent Technologies, Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$0.38 (vs US$1.10 in 3Q 2022)

Agilent Technologies, Inc. to Report Q3, 2023 Results on Aug 15, 2023

Agilent Technologies Inc. Announces the Launch of New Gen6 Software for All Agilent BioTek Detection Instruments

Upcoming dividend of US$0.23 per share at 0.8% yield

Agilent Technologies Inc. Introduces New Comprehensive GPC/SEC Solutions At HPLC 2023 Conference

Agilent Announces Biotek 406 Fx Washer Dispenser for Technology-Driven Workflow Efficiency

Agilent Technologies, Inc. Provides Earnings Guidance for the Third Quarter and Full Year Ended 2023

Second quarter 2023 earnings released: EPS: US$1.02 (vs US$0.92 in 2Q 2022)

Agilent Technologies, Inc. Announces Cash Dividend, Payable on July 26, 2023

Upcoming dividend of US$0.23 per share at 0.7% yield

First quarter 2023 earnings released: EPS: US$1.19 (vs US$0.94 in 1Q 2022)

Agilent Technologies Inc. Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance

Agilent Technologies, Inc., Annual General Meeting, Mar 15, 2023

Agilent Technologies, Inc. to Report Q1, 2023 Results on Feb 28, 2023

Agilent Technologies, Inc. (NYSE:A) announces an Equity Buyback for $2,000 million worth of its shares.

Agilent Technologies, Inc. (NYSE : A) acquired Avida Biomed Inc.

Upcoming dividend of US$0.23 per share

Full year 2022 earnings released: EPS: US$4.19 (vs US$3.98 in FY 2021)

Insider recently sold €4.3m worth of stock

Agilent Technologies, Inc.'s ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer

Independent Non-Executive Chairman recently sold €1.9m worth of stock

Principal Accounting Officer recently sold €698k worth of stock

Full year 2022 earnings released: EPS: US$4.19 (vs US$3.98 in FY 2021)

Agilent Technologies, Inc. Provides Revenue Guidance for the First Quarter and Year Full Year 2023

Agilent Technologies Inc. Announces Quarterly Cash Dividend, Payable on January 25, 2023

Agilent Announces AssayMAP Bravo Protein Sample Prep Workbench 4.0

Agilent Technologies, Inc. to Report Q4, 2022 Results on Nov 21, 2022

Agilent Technologies Inc. Announces Release of its Enhanced 8700 LDIR Chemical Imaging System for Microplastics Analysis

Insider recently sold €268k worth of stock

Agilent Technologies Inc. Announces Quarterly Cash Dividend, Payable on October 26, 2022

Insider recently sold €338k worth of stock

Third quarter 2022 earnings released: EPS: US$1.10 (vs US$0.87 in 3Q 2021)

Agilent Technologies, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2022

Agilent Technologies, Inc. (NYSE:A) acquired PSS Polymer Standards Service GmbH.

Agilent Technologies, Inc. to Report Q3, 2022 Results on Aug 16, 2022

Insider recently sold €113k worth of stock

Upcoming dividend of US$0.21 per share

Insider recently sold €698k worth of stock

Agilent Technologies, Inc. Announces New Oligonucleotide Analysis Software for Biopharma Research

Agilent Technologies, Inc. Releases IVDR-Compliant Instruments, Kits, and Reagents for Use in the European Union